Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Interrelation between miRNAs Expression Associated with Redox State Fluctuations, Immune and Inflammatory Response Activation, and Neonatal Outcomes in Complicated Pregnancy, Accompanied by Placental Insufficiency. | Antioxidants (Basel) | 2022 | 36670868 | PubTator, text mining | PubMed |
| MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2. | Ann Transl Med | 2022 | 36660663 | PubTator, text mining | PubMed |
| Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways. | Int J Mol Sci | 2022 | 36614139 | PubTator, text mining | PubMed |
| Regulation of Kinase Signaling Pathways by α6β4-Integrins and Plectin in Prostate Cancer. | Cancers (Basel) | 2022 | 36612146 | PubTator, text mining | PubMed |
| Passive Microwave Radiometry and microRNA Detection for Breast Cancer Diagnostics. | Diagnostics (Basel) | 2022 | 36611410 | PubTator, text mining | PubMed |
| Identification of Human miRNA Biomarkers Targeting the SARS-CoV-2 Genome. | ACS Omega | 2022 | 36570256 | PubTator, text mining | PubMed |
| Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness. | Cancer Cell Int | 2022 | 36567312 | PubTator, text mining | PubMed |
| The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets. | Front Oncol | 2022 | 36561529 | PubTator, text mining | PubMed |
| Investigation of MicroRNA Biomarkers in Equine Distal Interphalangeal Joint Osteoarthritis. | Int J Mol Sci | 2022 | 36555166 | PubTator, text mining | PubMed |
| Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. | Genes (Basel) | 2022 | 36553635 | PubTator, text mining | PubMed |
| The Biological Effect of Small Extracellular Vesicles on Colorectal Cancer Metastasis. | Cells | 2022 | 36552835 | PubTator, text mining | PubMed |
| Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. | Antioxidants (Basel) | 2022 | 36552560 | PubTator, text mining | PubMed |
| The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination. | Cancers (Basel) | 2022 | 36551515 | PubTator, text mining | PubMed |
| Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases. | Biosensors (Basel) | 2022 | 36551041 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
| Interferon and interferon-stimulated genes in HBV treatment. | Front Immunol | 2022 | 36531993 | PubTator, text mining | PubMed |
| MicroRNA-340 and MicroRNA-450b-5p: Plasma Biomarkers for Detection of Non-Small-Cell Lung Cancer. | J Environ Public Health | 2022 | 36531335 | PubTator, text mining | PubMed |
| miR-17-92 cluster in osteoarthritis: Regulatory roles and clinical utility. | Front Genet | 2022 | 36523768 | PubTator, text mining | PubMed |
| MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin. | Mol Med | 2022 | 36517751 | PubTator, text mining | PubMed |
| Preeclampsia and syncytiotrophoblast membrane extracellular vesicles (STB-EVs). | Clin Sci (Lond) | 2022 | 36511102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=21